Xiaoping Li

2.4k total citations · 1 hit paper
89 papers, 1.6k citations indexed

About

Xiaoping Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoping Li has authored 89 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoping Li's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (5 papers). Xiaoping Li is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (5 papers). Xiaoping Li collaborates with scholars based in China, United States and Singapore. Xiaoping Li's co-authors include Sara Marietti, Aleksandar Petlickovski, Simona Sica, Dimitar G. Efremov, Giuseppe Leone, Patrizia Chiusolo, Luca Laurenti, Qi Zhang, Jiahua Yang and Gang Liu and has published in prestigious journals such as Blood, PLoS ONE and Biochemistry.

In The Last Decade

Xiaoping Li

82 papers receiving 1.6k citations

Hit Papers

Roles of macrophages on ulcerative colitis and colitis-as... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Li China 21 783 230 221 194 183 89 1.6k
Shinpei Nakazawa Japan 24 611 0.8× 212 0.9× 205 0.9× 82 0.4× 93 0.5× 105 1.7k
Claudia C.S. Chini United States 25 1.1k 1.3× 367 1.6× 76 0.3× 176 0.9× 165 0.9× 40 3.1k
Lisa Olson United States 23 477 0.6× 292 1.3× 73 0.3× 111 0.6× 87 0.5× 46 2.3k
Maria Grazia Cattaneo Italy 26 827 1.1× 137 0.6× 76 0.3× 191 1.0× 162 0.9× 72 1.9k
John N. Snouwaert United States 22 1.3k 1.7× 476 2.1× 76 0.3× 263 1.4× 112 0.6× 40 2.8k
Edward T. Parkin United Kingdom 25 1.3k 1.7× 133 0.6× 64 0.3× 211 1.1× 119 0.7× 55 2.7k
Elisabeth Lang Germany 32 918 1.2× 212 0.9× 121 0.5× 103 0.5× 63 0.3× 62 2.9k
Karen E. Sheppard Australia 27 1.5k 1.9× 198 0.9× 93 0.4× 75 0.4× 262 1.4× 68 2.7k
Sun On Chan Hong Kong 29 955 1.2× 236 1.0× 85 0.4× 659 3.4× 160 0.9× 147 2.5k

Countries citing papers authored by Xiaoping Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Li more than expected).

Fields of papers citing papers by Xiaoping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Li. The network helps show where Xiaoping Li may publish in the future.

Co-authorship network of co-authors of Xiaoping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Li. A scholar is included among the top collaborators of Xiaoping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Li. Xiaoping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Junkai, Xiaoping Li, Xuan Liu, et al.. (2025). Semaglutide ameliorates metabolic disorders in offspring via regulation of oocyte ROS of pre-pregnancy obesity mice. Acta Pharmacologica Sinica. 46(6). 1664–1675. 1 indexed citations
3.
Liu, Shan, et al.. (2024). Global hotspots and trends in tea anti-obesity research: a bibliometric analysis from 2004 to 2024. Frontiers in Nutrition. 11. 1496582–1496582. 2 indexed citations
5.
Li, Xiaoping, Junkai Zhang, Shengnan Chen, et al.. (2024). Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction. Redox Biology. 72. 103129–103129. 37 indexed citations
6.
Li, Xiaoping, et al.. (2023). Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Frontiers in Immunology. 14. 1103617–1103617. 106 indexed citations breakdown →
7.
8.
Chen, Yue, et al.. (2023). Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression. Clinical Science. 137(17). 1391–1407. 3 indexed citations
9.
Li, Xiaoping, et al.. (2023). Causal effects of dietary habits on COVID-19 susceptibility, hospitalisation and severity: a comprehensive Mendelian randomisation study. British Journal Of Nutrition. 131(6). 1007–1014. 1 indexed citations
10.
Zhang, Xiaoyun, Yuqing Li, Jiaofeng Gui, et al.. (2023). Predicting depressive symptom by cardiometabolic indicators in mid-aged and older adults in China: a population-based cross-sectional study. Frontiers in Psychiatry. 14. 1153316–1153316. 22 indexed citations
11.
Gui, Jiaofeng, Yuqing Li, Haiyang Liu, et al.. (2023). Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Frontiers in Public Health. 11. 1073824–1073824. 49 indexed citations
12.
Chen, Shengnan, et al.. (2022). Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway. Frontiers in Pharmacology. 13. 860944–860944. 20 indexed citations
13.
Zheng, Haoyi, et al.. (2022). Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. Theriogenology. 198. 30–35. 2 indexed citations
14.
Huang, Fang, Wenxia Ma, Hui Zheng, et al.. (2021). Early risk factors for extrapulmonary organ injury in adult COVID-19 patients. Annals of Translational Medicine. 9(8). 701–701. 3 indexed citations
15.
Feng, Yimei, Ping Wang, Wen Zhu, et al.. (2020). Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study. Frontiers in Medicine. 7. 110–110. 31 indexed citations
16.
Li, Xiaoping, et al.. (2018). Effects of logotherapy on self-perceived burden and hope in cervical cancer patients after surgery. Zhonghua xiandai huli zazhi. 24(36). 4393–4396. 1 indexed citations
18.
Shao, Shiyun, Kaiquan Shen, Einar Wilder‐Smith, & Xiaoping Li. (2011). Effect of pain perception on the heartbeat evoked potential. Clinical Neurophysiology. 122(9). 1838–1845. 62 indexed citations
19.
Li, Xiaoping. (2005). Chinese Drugs of Reinforcing Kidney ,Clearing Liver ,and Activating Blood for Treat ment of Infertility Caused by Polycystic Ovary Syndrome. 2 indexed citations
20.
Knapp, Richard J., Ewa Malatyńska, Lei Fang, et al.. (1994). Identification of a human delta opioid receptor: Cloning and expression. Life Sciences. 54(25). PL463–PL469. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026